West will be showcasing its range of packaging components and drug delivery solutions, including NovaPure components, LyoSeal caps, and the SmartDose platform.
West Pharmaceutical Services, a manufacturer of packaging components and delivery systems for the pharmaceutical industry, will present an educational seminar on the value of plastic caps for injectable drug vial closure at CPhI Worldwide 2017, taking place Oct. 24–26, 2017 in Frankfurt, Germany. West will also be showcasing its range of packaging components and drug delivery solutions, including NovaPure components, LyoSeal caps, and the SmartDose platform.
Sylvia Marzotko, senior manager, Global Product Management, Vial, Containment & Delivery at West, will present an educational session on industry trends driving the adoption of plastic caps as an alternative to aluminum seals in injectable drug packaging:
Emergence of Plastic Caps-Market Drivers and Key Considerations for Assessment
Oct. 25, 1:35–2:05 p.m.
Marzotko will discuss the growing market need for innovation in sealing solutions for injectable drug vials and present an overview of key assessment criteria for evaluating when, how, and where plastic caps can be a viable solution in current pharmaceutical fill-finish processes.
Source: West Pharmaceutical Services, Stand 42G30
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Exosomes Field Advances with Milestones Achieved by EXO Biologics and ExoXpert
December 4th 2024EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.